Print ISSN:-2395-1354

Online ISSN:-2395-1362

CODEN : IJOSHC

Article History

Received : 07-01-2024

Accepted : 02-04-2024



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 236

PDF Downloaded: 146


Can we treat idiopathic CTEV without tenotomy? A prospective study


Full Text PDF Share on Facebook Share on Twitter


Original Article

Author Details : Pandiyarajan E*, Alok Chandra Agrawal, Deepak Kumar Garg, Santosh Kumar Yadav

Volume : 10, Issue : 2, Year : 2024

Article Page : 108-111

https://doi.org/10.18231/j.ijos.2024.018



Suggest article by email

Get Permission

Abstract

Tendoachillis tenotomy is the procedure of choice to correct equinus deformity in Ponseti technique. Though Tenotomy is the most frequently done procedure, is associated with complications in 11% to 50% of cases. So, we were in search of an alternative which would have less complication and will give similar results to a standard tenotomy. One such method is Botulinum toxin type A injection into the gastronemius-soleus muscle which causes reversible paralysis of the muscle leading to lengthening of muscle unit, easy manipulation and casting. In our study, we compared the outcomes of Botulinum toxin with tenotomy in the correction of hindfoot equinus in children (<2>0.05) between the two groups in the post-intervention Pirani score and ankle dorsiflexion was seen at 3&6 weeks and 3,6,12 month post intervention. Average dorsiflexion was around 11±1º in both groups upto 1 year post intervention. Early results shows that Botulinum toxin type A is a good alternative to a routine tendoachillis tenotomy to correct hindfoot equinus in the management of clubfoot by the Ponseti method.
 

Keywords: Ponseti, Tenotomy, Botulinum toxin type A, CTEV.



How to cite : Pandiyarajan E, Agrawal A C, Garg D K, Yadav S K, Can we treat idiopathic CTEV without tenotomy? A prospective study. Indian J Orthop Surg 2024;10(2):108-111


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.